Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Resverlogix and Sun Health Research Institute collaborate for treatment of AD

June 22, 2007

Liraglutide provides better glucose control than insulin glargine in phase III study

June 22, 2007

Merck Serono and Ambrx collaborate on growth hormone products

June 22, 2007

Novel agents for treating endocrine-related disorders disclosed in recent patent literature

June 22, 2007

BioSante and Pantarhei evaluate new oral contraceptive in phase II trial

June 21, 2007

Keryx completes patient randomization for Sulonex phase III study

June 20, 2007

Recent patents report novel therapeutic agents for metabolic disorders

June 20, 2007

Expanded access program opens for Kuvan

June 19, 2007

Bazedoxifene/conjugated estrogens improves BMD in postmenopausal women

June 19, 2007

NuvaRing approved in additional E.U. countries

June 19, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...